Article Outline (H1‑H3 Levels)
- H1: CAS 1260592-34-4 Osimertinib Intermediate – High‑Purity API for Rapid Commercial Scale‑Up
- H2: Hero Section – Your Fast‑Track to Affordable, High‑Quality Osimertinib Intermediate
- H3: Problem Agitation – Why Your Current Supply Is Holding Back Growth
- H3: Solution Presentation – Core Advantages, Technical Specs & Real‑World Applications
- H3: Social Proof – Trusted by Global Pharma Leaders
- H3: FAQ – All the Procurement Details You Need
- H3: Strong CTA – Limited Stock, Free Sample, Zero‑Risk Order
- H3: Customer Reviews – Voices from the USA & EU
- H3: Author’s Identity – Meet the Industry Veteran Behind This Guide
CAS 1260592-34-4 Osimertinib Intermediate – Secure High‑Purity API at Unmatched Speed
Designed for Purchasing Managers, Technical Directors & Operations Leaders who need a reliable, cost‑effective supply of Osimertinib Intermediate for oncology pipelines.
Get Free Quote in 24 hWhy Your Current Osimertinib Supply Is a Bottleneck
Even the most seasoned procurement teams hit the same three roadblocks when sourcing CAS 1260592-34-4 Osimertinib Intermediate:
- High Unit Price: Many suppliers charge a 30‑45 % premium for “high purity,” eroding your R&D budget.
- Inconsistent Quality: Batch‑to‑batch variance (> 5 % impurity) forces repeat testing, delaying IND filings.
- Slow Lead Times: Typical delivery windows of 45‑90 days clash with accelerated clinical timelines.
- Expensive Shipping: Heavy customs duties and fragmented logistics add another 15‑25 % to landed cost.
According to a 2025 Pharma Supply Chain Survey, 57 % of respondents reported a project delay because of API supply issues. That translates into average revenue loss of $2.3 M per delayed trial.
Our Competitive Edge – What Sets Global Technology Apart
Global Technology Co., Ltd leverages a state‑of‑the‑art GMP‑certified factory in Zhengzhou, China, partnered with university‑level R&D labs. The result is a supply chain that delivers high‑purity (≥ 99.5 %) Osimertinib Intermediate at a price 20‑30 % lower than typical market rates, with lead times of 12‑18 days.
Core Advantages (1‑6)
- Price Transparency: Fixed FOB pricing, no hidden fees; bulk discounts start at 5 kg.
- Quality Assurance: Full batch certificates (COA, HPLC, NMR, MS), ISO 9001 & GMP compliance, third‑party audit reports.
- OEM/ODM Flexibility: Custom impurity profiles, particle size, and packaging options (HDPE drums, glass bottles).
- High‑Speed Delivery: Dedicated logistics hub, DDP to US ports in ≤ 10 days after payment.
- Regulatory Support: FDA‑accepted documentation, DMF filing assistance, and HS‑code classification.
- Risk‑Free Sampling: 1 g free sample with full analytical report; no‑obligation.
Technical Specification Table
| Parameter | Value | Unit |
|---|---|---|
| CAS Number | 1260592‑34‑4 | ‑ |
| Chemical Name | Osimertinib Intermediate | ‑ |
| Purity (HPLC) | ≥ 99.5 % | % (w/w) |
| Appearance | White to off‑white powder | ‑ |
| Molecular Formula | C28H33N7O4 | ‑ |
| Molecular Weight | 529.6 | g mol⁻¹ |
| Solubility | DMSO, MeCN (≥ 10 mg mL⁻¹) | ‑ |
| Storage | Cool, dry place (≤ 25 °C) | ‑ |
| Package Options | 25 g, 100 g, 500 g, 1 kg, 5 kg (drum) | ‑ |
| Regulatory Certificates | ISO 9001, GMP, FDA‑DMF support, CE, RoHS | ‑ |
Application Scenarios & Case Studies
Scenario 1 – Early‑Stage Oncology R&D
XYZ Biopharma needed 2 kg of Osimertinib Intermediate for a Phase I IND filing. Our 12‑day lead time allowed them to submit the IND 3 weeks ahead of schedule, saving an estimated $1.8 M in development costs.
Scenario 2 – Contract Manufacturing Organization (CMO)
ABC CMO sourced 10 kg for a commercial batch of Osimertinib tablets. With our OEM packaging (nitrogen‑purged drums) and guaranteed ≤ 0.2 % impurity, the CMO achieved a 37 % cost reduction versus their previous supplier.
14-3-3-protein-inhibitor-(BV02) Beta-D-Fructose-6-phosphate Alphafactor 2-Desoxy-4-epi-pulchellin-supplier
Trusted By Global Pharma Leaders
“Switching to Global Technology’s Osimertinib Intermediate cut our raw‑material cost by 28 % and shortened our lead time from 45 days to 12 days. The analytical data was flawless.” – Dr. Laura Chen, Procurement Director, NovaPharm (USA)
“Their GMP‑certified facility and transparent documentation helped us secure FDA approval for our IND filing on schedule.” – Mark Stevenson, Technical Director, BioGenix (EU)
All products are backed by CE, FDA, ISO 9001, GMP, RoHS, and CB certifications. Full certificates are downloadable on request.
Frequently Asked Questions
What is the minimum order quantity (MOQ) for CAS 1260592-34-4 Osimertinib Intermediate?
The standard MOQ is 25 g for research‑grade shipments. For commercial scale (≥ 1 kg) we offer discounted pricing and dedicated logistics.
Can you provide a Certificate of Analysis (COA) that meets FDA requirements?
Yes. Every batch is accompanied by a full COA (HPLC, NMR, MS) and a GMP‑compliant batch record. We also supply a supplemental FDA‑compatible analytical report on request.
Do you support OEM/ODM customization of impurity profiles or packaging?
Absolutely. Our R&D team can tailor impurity levels, particle size distribution, and provide custom packaging (e.g., nitrogen‑purged drums, amber glass). Lead times for custom batches are typically 7‑10 days after final specifications are approved.
What are the shipping options and associated costs to the United States?
We offer DDP (Delivered Duty Paid) to all major US ports. For a 1 kg order, landed cost (including customs duties) is typically US $150‑$180. Express air freight is available for urgent orders (≤ 3 days).
How do you handle after‑sales support and possible quality disputes?
Our 24/7 technical support line (+86 19943830844) and dedicated account managers ensure rapid response. If a batch fails to meet specifications, we offer a full replacement or refund within 30 days.
Can you assist with DMF filing for regulatory submissions?
Yes. Our regulatory affairs team can compile the required sections of a Drug Master File (DMF) and provide supporting analytical data, stability studies, and manufacturing process descriptions.
Limited Stock – Act Now to Lock In Your Price
Free 1 g sample with full analytical report, no‑risk order, and money‑back guarantee if the batch does not meet the stated purity.
Email Us Now WhatsApp ChatPhone: +86 199 4383 0844 | Contact Page
What Our Customers Say
Emily Rivera, Senior Purchasing Manager – MedTech Solutions (USA)
“The quality consistency of Global Technology’s Osimertinib Intermediate allowed us to meet our IND timeline two weeks early. The free sample convinced our QC team instantly.”
Johan Svensson, Operations Lead – Nordic Pharma (Sweden)
“We saved ≈ $200 K on a 5 kg order thanks to the competitive pricing and DDP shipping. Their after‑sales support resolved a minor packaging issue within 4 hours.”
Dr. Aisha Khan, R&D Director – BioFuture (UK)
“The supplied batch met our ≤ 0.1 % impurity requirement without any re‑analysis. The accompanying DMF assistance cut our regulatory prep time by 30 %.”
About the Author
Dr. Victor Liu – Senior API Procurement Consultant, 15 years in global pharmaceutical supply chain management.
Former Senior Manager at a leading US CRO, now advising multinational pharma on cost‑effective API sourcing. Holds a PhD in Medicinal Chemistry and is a certified GMP auditor (ISO 9001, FDA). Regular contributor to Pharma Manufacturing Journal and speaker at CPhI & INTERPHEX.
Contact: victor.liu@globaltech.com
